2023 is the year of Ozempic. The FDA first approved Ozempic, a semaglutide medication from Novo Nordisk, back in 2017, but the drug went mainstream in 2022.1 And by April of 2023 it had reached household recognition status. The court of public opinion regarding Semaglutide remains split, with one camp celebrating its potential to overall […]